Stuttgart - Delayed Quote • EUR
SELLAS Life Sciences Group Inc (RXK2.SG)
As of November 7 at 4:16 PM GMT+1. Market Open.
Loading Chart for RXK2.SG
DELL
- Previous Close
0.1100 - Open
0.1170 - Bid 0.1130 x --
- Ask 0.1320 x --
- Day's Range
0.1080 - 0.1500 - 52 Week Range
0.1080 - 5.5000 - Volume
10,000 - Avg. Volume
0 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 9, 2024 - May 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: RXK2.SG
Performance Overview: RXK2.SG
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
RXK2.SG
98.00%
S&P 500
6.33%
1-Year Return
RXK2.SG
98.00%
S&P 500
22.70%
3-Year Return
RXK2.SG
98.00%
S&P 500
21.33%
5-Year Return
RXK2.SG
99.73%
S&P 500
72.88%
Compare To: RXK2.SG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RXK2.SG
Valuation Measures
As of 4/24/2024
Market Cap
80.96M
Enterprise Value
79.44M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-2.10
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Company Insights: RXK2.SG
RXK2.SG does not have Company Insights